EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Modulating the cleavage and polyadenylation site: from research tools to therapeutic opportunities

Fengyi Ma, Bin Tian

RNA · 2026

DOI: 10.1261/rna.080927.125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RNA, 2026. Verfasst von Fengyi Ma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. Hauptthemen laut MEDLINE: Polyadenylation, RNA, Messenger. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Almost all protein-coding and long noncoding genes that are transcribed by RNA polymerase II employ cleavage and polyadenylation (CPA) for 3' end maturation of their nascent RNAs. More than 70% of human mRNA genes display alternative polyadenylation (APA), resulting in expression of isoforms using different polyA sites (PAS). APA isoforms often have distinct mRNA metabolism and/or contain variable coding sequences. PAS mutations and genetic variations have been implicated in a growing number of human pathological conditions, underscoring the importance of PAS usage or selection for proper gene expression. Here we review approaches that modulate the usage of specific PAS using antisense- and CRISPR-based methods. We discuss applications of these strategies in the context of human diseases. We provide our perspectives on current challenges and future directions to advance PAS modulation in APA studies and development of related therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyadenylationRNA, MessengerHumansAnimalsGene Expression RegulationPoly A

Stichwörter der Autor:innen

genetic diseases3′ end processingCRISPRU7 snRNPalternative polyadenylationantisense oligonucleotides

Substanzen

RNA, MessengerPoly A

Autor:innen und Institutionen

  • Graduate Program in Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
  • Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
  • Genome Regulation and Cell Signaling Program, Ellen and Ronald Caplan Cancer Center, and Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
  • Graduate Program in Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA btian@wistar.org.

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Ma, F., & Tian, B. (2026). Modulating the cleavage and polyadenylation site: from research tools to therapeutic opportunities. RNA. https://doi.org/10.1261/rna.080927.125

Vancouver

Ma F, Tian B. Modulating the cleavage and polyadenylation site: from research tools to therapeutic opportunities. RNA. 2026. doi:10.1261/rna.080927.125

BibTeX
@article{Ma2026,
  author = {Ma, Fengyi and Tian, Bin},
  title = {Modulating the cleavage and polyadenylation site: from research tools to therapeutic opportunities},
  journal = {RNA},
  year = {2026},
  doi = {10.1261/rna.080927.125}
}
Kostenlos starten →